Literature DB >> 3257662

Alveolar-capillary block in patients with AIDS and Pneumocystis carinii pneumonia.

R M Sankary1, J Turner, A Lipavsky, E L Howes, J F Murray.   

Abstract

To determine the value of subdividing diffusing capacity for carbon monoxide (DL) in diagnosing and monitoring the course of Pneumocystis carinii pneumonia (PCP), we measured DL, membrane diffusing capacity (DM), and pulmonary capillary blood volume (VC) in 20 control subjects, 20 patients with a low DL (less than 75% predicted) and newly diagnosed PCP, and 16 patients with a low DL in most of whom PCP had been suspected and excluded. Ten patients with PCP were restudied approximately 60 days after treatment. When clinically indicated, lung biopsies were obtained for histologic examination. Compared with mean values in control subjects (DL = 92%, DM = 101%, and VC = 35 ml/m2), all values were decreased (p less than 0.01) in patients with PCP (DL = 58%, DM = 33%, and VC = 26 ml/m2) and in those without PCP (DL = 61%, DM = 56%, and VC = 22 ml/m2). Values of DM were significantly less (p less than 0.05) in patients with, than in those without, PCP. Analysis of lung biopsies by light and electron microscopy showed overlapping morphologic abnormalities in the 2 groups of patients. In the 10 patients with PCP restudied after successful treatment, the mean DL increased from 60 to 80% (p less than 0.0005), the DM increased from 35 to 108% (p less than 0.006), and the VC did not change. These results suggest that in contrast to most disorders in which DL is decreased, PCP causes reversible alveolar-capillary block.

Entities:  

Mesh:

Year:  1988        PMID: 3257662     DOI: 10.1164/ajrccm/137.2.443

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

Review 1.  AIDS and the lung. 4-- Non-invasive investigation of pulmonary disease in patients positive for the human immunodeficiency virus.

Authors:  A B Millar; D M Mitchell
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

2.  Pulmonary capillary blood volume in patients with probable pulmonary Kaposi's sarcoma.

Authors:  F Camus; C de Picciotto; J Gerbe; S Roy; O Bouchaud; E Casalino; C Perronne
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

3.  Pneumocystis pneumonia in HIV antibody positive patients.

Authors:  R Rodriguez-Roisin; J A Barberà; J Roca
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

4.  Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS.

Authors:  R B Nieman; J Fleming; R J Coker; J R Harris; D M Mitchell
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

5.  Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat.

Authors:  W R Rice; F M Singleton; M J Linke; P D Walzer
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.